1. Klein BR, Hedges TR 3rd, Dayal Y, Adelman LS. Orbital myositis and giant cell myocarditis. Neurology. 1989; 39:988–90.
Article
2. Seidenberg KB, Leib ML. Orbital myositis with Lyme disease. Am J Ophthalmol. 1990; 109:13–6.
Article
3. Volpe NJ, Shore JW. Orbital myositis associated with herpes zoster. Arch Ophthalmol. 1991; 109:471–2.
Article
4. Orssaud C, Poisson M, Gardeur D. [Orbital myositis, recurrence of Whipple's disease]. J Fr Ophtalmol. 1992; 15:205–8.
5. Mombaerts I, Schlingemann RO, Goldschmeding R, Koornneef L. Are systemic corticosteroids useful in the management of orbital pseudotumors? Ophthalmology. 1996; 103:521–8.
Article
6. Mombaerts I, Goldschmeding R, Schlingemann RO, Koornneef L. What is orbital pseudotumor? Surv Ophthalmol. 1996; 41:66–78.
Article
7. Maurer I, Zierz S. Recurrent orbital myositis: report of a familial incidence. Arch Neurol. 1999; 56:1407–9.
8. Prabhakaran VC, Saeed P, Esmaeli B. . Orbital and adnexal sarcoidosis. Arch Ophthalmol. 2007; 125:1657–62.
Article
9. Harper SL, Letko E, Samson CM. . Wegener's granulomatosis: the relationship between ocular and systemic disease. J Rheumatol. 2001; 28:1025–32.
10. Olsen KE, Sandgren O, Sletten K, Westermark P. Primary localized amyloidosis of the eyelid: two cases of immunoglobulin light chainderived proteins, subtype lambda V respectively lambda VI. Clin Exp Immunol. 1996; 106:362–6.
11. Braun RP, French LE, Massouyé I, Saurat JH. Periorbital oedema and erythema as a manifestation of discoid lupus erythematosus. Dermatology. 2002; 205:194–7.
Article
12. Katayama I, Koyano T, Nishioka K. Prevalence of eyelid dermatitis in primary Sjögren's syndrome. Int J Dermatol. 1994; 33:421–4.
Article
13. Drummond SR, Kemp EG. Successful medical treatment of ble-pharochalasis: a case series. Orbit. 2009; 28:313–6.
Article
14. Schäcke H, Döcke WD, Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther. 2002; 96:23–43.
15. Mombaerts I, Koornneef L. Current status in the treatment of orbital myositis. Ophthalmology. 1997; 104:402–8.
Article
16. Savino G, Balia L, Colucci D. . Intraorbital injection of ritux-imab: a new approach for active thyroidassociated orbitopathy, a prospective case series. Minerva Endocrinol. 2013; 38:173–9.
17. Yuen SJ, Rubin PA. Idiopathic orbital inflammation: distribution, clinical features, and treatment outcome. Arch Ophthalmol. 2003; 121:491–9.
18. Yuen SJ, Rubin PA. Idiopathic orbital inflammation: distribution, clinical features, and treatment outcome. Arch Ophthalmol. 2003; 121:491–9.